Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review.

Oura K, Morishita A, Tani J, Masaki T. · 2021

Read Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review. by Oura K, Morishita A, Tani J, Masaki T. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8198390.txt.

Introduction

Oura and co-authors review the immune setting of liver cancer and suppressive therapy for it. Hepatocellular carcinoma is the main form of liver cancer. It resists drugs and often returns after treatment.

New immune therapies have lengthened survival for some patients. A checkpoint inhibitor paired with a VEGF inhibitor now leads first-line care. How well these drugs work depends on the tumour immune setting. The review sums up that setting's parts and states. It aims to help doctors match patients to the right immune drugs. Resistance paths get close attention too.

Catalog record

CREATOROura K, Morishita A, Tani J, Masaki T.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE124 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8198390

Browse the full library · About the Tower of Babel